Reyataz

Atazanavir Sulfate

5.9 Moderate risk

Reyataz & Maternal exposure during pregnancy

6.4%

of users reported Maternal exposure during pregnancy

97.4%

also reported Severe reaction

100.0%

are women

Most common medical consequences

Severe reaction
97.4%
Hospitalization
2.6%

Have you experienced any negative side effects from this medication?

Reyataz: general information

Most common side effects (37)

Most commonly affected ages

0 - 9 years
2.4%
10 - 19 years
<0.1%
20 - 29 years
9.4%
30 - 39 years
28.7%
40 - 49 years
25.1%
50 - 59 years
25.8%
60 - 69 years
8.6%